CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-24 | GORDON KEVIN K Director | Sale | −1,410 | $38.24 | $54K | 12,354 |
| 2023-05-24 | GORDON KEVIN K Director | Grant or award · Stock Option (Right to Buy) | +16,990 | 16,990 | ||
| 2023-05-24 | Dean Lloyd H Director | Grant or award | +3,654 | 6,554 | ||
| 2023-05-24 | Dean Lloyd H Director | Grant or award · Stock Option (Right to Buy) | +16,990 | 16,990 | ||
| 2023-05-24 | Dean Lloyd H Director | Grant or award · Stock Option (Right to Buy) | +2,007 | $19.93 | $40K | 2,007 |
| 2023-05-24 | Cohen Fred E Director | Grant or award | +4,385 | 16,517 | ||
| 2023-05-24 | Cohen Fred E Director | Grant or award · Stock Option (Right to Buy) | +18,350 | 18,350 | ||
| 2023-05-16 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +4,608 | $3.95 | $18K | 220,532 |
| 2023-05-16 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,608 | $35.94 | $166K | 215,924 |
| 2023-05-16 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,153 | $35.94 | $41K | 36,597 |
| 2023-05-16 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −4,608 | 875,556 | ||
| 2023-05-15 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 247,924 |
| 2023-05-15 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −32,000 | $36.24 | $1.2M | 215,924 |
| 2023-05-15 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,000 | $36.24 | $290K | 31,655 |
| 2023-05-15 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 880,164 | ||
| 2023-05-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 247,924 |
| 2023-05-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −32,000 | $36.30 | $1.2M | 215,924 |
| 2023-05-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,000 | $36.30 | $290K | 39,655 |
| 2023-05-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 912,164 | ||
| 2023-05-11 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +32,000 | $3.95 | $126K | 247,924 |
Page 24 of 77 · 1,524 trades